Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Trickle Portfolio -- Ignore unavailable to you. Want to Upgrade?

To: tuck who wrote (415)	1/29/2001 4:52:24 PM
From: scaram(o)uche	Respond to of 1784

Molecular Devices Reports Record Revenues and Earnings for Fourth Quarter And Year Ended December 31, 2000 SUNNYVALE, Calif., Jan. 29 /PRNewswire/ -- Molecular Devices Corporation (Nasdaq: MDCC) today announced record revenues and earnings for the fourth quarter and year ended December 31, 2000. Revenues for the fourth quarter were $27,477,000, higher than any previous quarter in the Company's history and a 26% increase over sales reported in the same period last year. Revenues for the year were $96,035,000, or an increase of 34% compared to the year ended December 31, 1999. On a constant currency basis, fourth quarter revenues would have been $28.1 million, or 29% growth over last year. Operating income increased 61% and 102% in the fourth quarter and year ended December 31, 2000, respectively, as compared to operating income in the same periods last year (excluding the effect of a $15,181,000 charge related to the LJL BioSystems merger in third quarter of 2000 and a $2,037,000 write-off of acquired in-process research and development recorded in the second quarter of 1999). (snip)